swish30

DVAX - Potential continuation play intraday

做多
NASDAQ:DVAX   Dynavax Technologies Corporation
Advisory committee has voted in favour of Hepatitis-B vaccine. Now just waiting for FDA approval expected no later than November 10.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。